Biologic potential of amantadine-resistant influenza A virus in an avian model.
about
Pandemic Threat Posed by Avian Influenza A VirusesPerspectives on antiviral use during pandemic influenzaGenetics, receptor binding property, and transmissibility in mammals of naturally isolated H9N2 Avian Influenza virusesGeneration and characterization of a mutant of influenza A virus selected with the neuraminidase inhibitor BCX-140.Antiviral resistance and the control of pandemic influenzaImpact of emerging antiviral drug resistance on influenza containment and spread: influence of subclinical infection and strategic use of a stockpile containing one or two drugsEmergence of drug-resistant influenza virus: population dynamical considerations.Comparative dynamics and distribution of influenza drug resistance acquisition to protein m2 and neuraminidase inhibitors.Evolution of the H3 influenza virus hemagglutinin from human and nonhuman hosts.Influenza A viruses of swine circulating in the United States during 2009-2014 are susceptible to neuraminidase inhibitors but show lineage-dependent resistance to adamantanes.Detection and Genetic Characteristics of H9N2 Avian Influenza Viruses from Live Poultry Markets in Hunan Province, ChinaRecovery of drug-resistant influenza A virus during therapeutic use of rimantadine.Generation and characterization of recombinant influenza A (H1N1) viruses harboring amantadine resistance mutations.Reassortment and mutations associated with emergence and spread of oseltamivir-resistant seasonal influenza A/H1N1 viruses in 2005-2009.Specific structural alteration of the influenza haemagglutinin by amantadine.Expression of the influenza A virus M2 protein is restricted to apical surfaces of polarized epithelial cellsAdamantane resistance in seasonal human influenza A viruses from Calgary, Alberta (January 2007 to August 2008).Molecular aspects of avian influenza (H5N1) viruses isolated from humans.Adamantane-resistant influenza a viruses in the world (1902-2013): frequency and distribution of M2 gene mutations.Safety and prophylactic efficacy of low-dose rimantadine in adults during an influenza A epidemic.Characterization of mutants of influenza A virus selected with the neuraminidase inhibitor 4-guanidino-Neu5Ac2enCatalytic and framework mutations in the neuraminidase active site of influenza viruses that are resistant to 4-guanidino-Neu5Ac2en.Antiviral therapy: current concepts and practicesInsight into alternative approaches for control of avian influenza in poultry, with emphasis on highly pathogenic H5N1Biologic importance of neuraminidase stalk length in influenza A virusAttenuation of influenza A virus by insertion of a foreign epitope into the neuraminidase.Evolutionary analysis of the influenza A virus M gene with comparison of the M1 and M2 proteins.In vitro and in vivo activities of aminoadamantane and aminoalkylcyclohexane derivatives against Trypanosoma brucei.Isolation of amantadine-resistant influenza a viruses (H3N2) from patients following administration of amantadine in JapanIndependence of evolutionary and mutational rates after transmission of avian influenza viruses to swine.Oral administration of cyclopentane neuraminidase inhibitors protects ferrets against influenza virus infection.Generation and characterization of variants of NWS/G70C influenza virus after in vitro passage in 4-amino-Neu5Ac2en and 4-guanidino-Neu5Ac2en.Characterization of the complete genome of influenza A (H5N1) virus isolated during the 2006 outbreak in poultry in India.Novel assay for the influenza virus M2 channel activity.Emergence and transmission of amantadine-resistant influenza A in a nursing home.Characterization of avian influenza H9N2 viruses isolated from ostriches (Struthio camelus).Unlocking pandemic potential: prevalence and spatial patterns of key substitutions in avian influenza H5N1 in Egyptian isolates.
P2860
Q22299330-79AF85BA-1FCE-4A60-8633-1DCCF36ED610Q24522384-56FA4055-974F-4EBE-A586-D6FE0703DA09Q27322724-D6BA9709-E8F8-4BBE-8B99-DA08703C2321Q28379467-7B2E2BDE-5BFE-4FB2-A81D-D472E50920C7Q28469119-904DAD4D-FBAF-4F13-86D4-7CEDC4719DFEQ28472846-16F7E18F-0A11-4678-86DF-DF08E5E91A20Q30353989-7F5768BB-8B7B-4F8A-92B6-9AD929187ED7Q30355434-75A73FFB-2B70-4D2B-880C-C0C4EA98C377Q30359951-88F2D053-5F93-43C7-96EA-8A23D1BF88DEQ30371953-18A6BE7E-4D79-45B9-A00E-DB6F9A2A2A51Q30381221-F8DE5D45-152F-4853-97B7-3B9FC4F01C41Q30448585-C6C72756-497F-4059-B1B9-3ED3EFF42563Q33804210-1AF57367-0110-4FE6-B843-6F601A45BE7AQ33869689-E2487736-8711-4B62-B6D9-6BF5284552DFQ33922433-7E7DD019-66BA-4DE6-BB57-025B648B325FQ33936440-D7F0DB83-1A40-4C4A-B185-E7BEDD33CB2DQ34028343-C9E2C92A-5F4B-4588-B3A1-083A5D3BB52BQ34051765-AB5A77E1-8203-4479-B989-D9CB728E69FDQ35175284-F1447E83-A2FE-466E-826F-CC700771A244Q35271460-72291CB4-BB62-433C-854C-C2F2F96AEEC3Q35857200-6051EF90-7E72-4FAE-9419-87BDA526AB46Q35882160-7178E949-0F81-4EEB-9BC3-81BDB2B578ACQ36070394-56B073DA-E346-4D91-B16B-DBBE7873C484Q36432764-B3348AC0-D1DD-4D80-86A5-DB7E5C9AAD3DQ36640894-0C9AEB50-40C2-4ED5-A8FF-63B7BE7E1B7CQ36699442-1CDCADDD-6542-49D8-8A3B-14703E4C95B3Q36798311-57F01845-BCD8-4690-9AD1-4CBE9DCB1E01Q39127478-700F0659-C9A2-4CF4-935D-5299896E4634Q39464368-3B9C8445-02A9-4702-B7C2-DBF3F2F2CFD8Q39551661-7C8BC70B-978F-4B1A-A83F-AE07F9A1F307Q39651456-17D911A9-7985-4222-BB78-7F3E450B05E1Q39781147-45D33326-999D-4408-A775-E03B38036A03Q43175875-E97B0E00-FE96-4E91-B221-3282CCC114ECQ44963422-ECB911E0-CF1A-4188-9BE1-D7EEEFD130B1Q45280919-47CA1716-EA5D-41CE-B54A-FB0C52DA36AEQ49358430-4C7CBB0D-964A-4868-8A53-B0AFFD5615C3Q55491209-24867CAB-6531-495C-85C2-32572974E0FE
P2860
Biologic potential of amantadine-resistant influenza A virus in an avian model.
description
1989 nî lūn-bûn
@nan
1989年の論文
@ja
1989年学术文章
@wuu
1989年学术文章
@zh
1989年学术文章
@zh-cn
1989年学术文章
@zh-hans
1989年学术文章
@zh-my
1989年学术文章
@zh-sg
1989年學術文章
@yue
1989年學術文章
@zh-hant
name
Biologic potential of amantadine-resistant influenza A virus in an avian model.
@en
Biologic potential of amantadine-resistant influenza A virus in an avian model.
@nl
type
label
Biologic potential of amantadine-resistant influenza A virus in an avian model.
@en
Biologic potential of amantadine-resistant influenza A virus in an avian model.
@nl
prefLabel
Biologic potential of amantadine-resistant influenza A virus in an avian model.
@en
Biologic potential of amantadine-resistant influenza A virus in an avian model.
@nl
P2093
P356
P1476
Biologic potential of amantadine-resistant influenza A virus in an avian model.
@en
P2093
P304
P356
10.1093/INFDIS/159.6.1050
P407
P577
1989-06-01T00:00:00Z